Cargando…

Comparison of serum acylcarnitine levels in patients with myalgic encephalomyelitis/chronic fatigue syndrome and healthy controls: a systematic review and meta-analysis

BACKGROUND: Myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease (ME/CFS/SEID) is a condition diagnosed primarily based on clinical symptoms, including prolonged fatigue and post-exertional malaise; however, there is no specific test for the disease. Additionally,...

Descripción completa

Detalles Bibliográficos
Autores principales: Jinushi, Ryuhei, Masuda, Sakue, Tanisaka, Yuki, Nishiguchi, Sho, Shionoya, Kento, Sato, Ryo, Sugimoto, Kei, Shin, Takahiro, Shiomi, Rie, Fujita, Akashi, Mizuide, Masafumi, Ryozawa, Shomei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280864/
https://www.ncbi.nlm.nih.gov/pubmed/37337273
http://dx.doi.org/10.1186/s12967-023-04226-z
_version_ 1785060891093368832
author Jinushi, Ryuhei
Masuda, Sakue
Tanisaka, Yuki
Nishiguchi, Sho
Shionoya, Kento
Sato, Ryo
Sugimoto, Kei
Shin, Takahiro
Shiomi, Rie
Fujita, Akashi
Mizuide, Masafumi
Ryozawa, Shomei
author_facet Jinushi, Ryuhei
Masuda, Sakue
Tanisaka, Yuki
Nishiguchi, Sho
Shionoya, Kento
Sato, Ryo
Sugimoto, Kei
Shin, Takahiro
Shiomi, Rie
Fujita, Akashi
Mizuide, Masafumi
Ryozawa, Shomei
author_sort Jinushi, Ryuhei
collection PubMed
description BACKGROUND: Myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease (ME/CFS/SEID) is a condition diagnosed primarily based on clinical symptoms, including prolonged fatigue and post-exertional malaise; however, there is no specific test for the disease. Additionally, diagnosis can be challenging since healthcare professionals may lack sufficient knowledge about the disease. Prior studies have shown that patients with ME/CFS/SEID have low serum acylcarnitine levels, which may serve as a surrogate test for patients suspected of having this disease. This systematic review and meta-analysis aimed to investigate the differences in serum acylcarnitine levels between patients with ME/CFS/SEID and healthy controls. METHODS: This systematic review was conducted using PubMed and Ichushi-Web databases. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement, we included all studies from the databases’ inception until February 17, 2023, that evaluated blood tests in both patients with ME/CFS/SEID and healthy control groups. The primary endpoint was the difference in serum acylcarnitine levels between the two groups. RESULTS: The electronic search identified 276 studies. Among them, seven met the eligibility criteria. The serum acylcarnitine levels were analyzed in 403 patients with ME/CFS/SEID. The patient group had significantly lower serum acylcarnitine levels when compared with the control group, and the statistical heterogeneity was high. CONCLUSION: The patient group had significantly lower serum acylcarnitine levels when compared with the control group. In the future, the measurement of serum acylcarnitine levels, in addition to clinical symptoms, may prove to be a valuable diagnostic tool for this condition. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-023-04226-z.
format Online
Article
Text
id pubmed-10280864
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102808642023-06-21 Comparison of serum acylcarnitine levels in patients with myalgic encephalomyelitis/chronic fatigue syndrome and healthy controls: a systematic review and meta-analysis Jinushi, Ryuhei Masuda, Sakue Tanisaka, Yuki Nishiguchi, Sho Shionoya, Kento Sato, Ryo Sugimoto, Kei Shin, Takahiro Shiomi, Rie Fujita, Akashi Mizuide, Masafumi Ryozawa, Shomei J Transl Med Review BACKGROUND: Myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease (ME/CFS/SEID) is a condition diagnosed primarily based on clinical symptoms, including prolonged fatigue and post-exertional malaise; however, there is no specific test for the disease. Additionally, diagnosis can be challenging since healthcare professionals may lack sufficient knowledge about the disease. Prior studies have shown that patients with ME/CFS/SEID have low serum acylcarnitine levels, which may serve as a surrogate test for patients suspected of having this disease. This systematic review and meta-analysis aimed to investigate the differences in serum acylcarnitine levels between patients with ME/CFS/SEID and healthy controls. METHODS: This systematic review was conducted using PubMed and Ichushi-Web databases. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement, we included all studies from the databases’ inception until February 17, 2023, that evaluated blood tests in both patients with ME/CFS/SEID and healthy control groups. The primary endpoint was the difference in serum acylcarnitine levels between the two groups. RESULTS: The electronic search identified 276 studies. Among them, seven met the eligibility criteria. The serum acylcarnitine levels were analyzed in 403 patients with ME/CFS/SEID. The patient group had significantly lower serum acylcarnitine levels when compared with the control group, and the statistical heterogeneity was high. CONCLUSION: The patient group had significantly lower serum acylcarnitine levels when compared with the control group. In the future, the measurement of serum acylcarnitine levels, in addition to clinical symptoms, may prove to be a valuable diagnostic tool for this condition. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-023-04226-z. BioMed Central 2023-06-19 /pmc/articles/PMC10280864/ /pubmed/37337273 http://dx.doi.org/10.1186/s12967-023-04226-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Jinushi, Ryuhei
Masuda, Sakue
Tanisaka, Yuki
Nishiguchi, Sho
Shionoya, Kento
Sato, Ryo
Sugimoto, Kei
Shin, Takahiro
Shiomi, Rie
Fujita, Akashi
Mizuide, Masafumi
Ryozawa, Shomei
Comparison of serum acylcarnitine levels in patients with myalgic encephalomyelitis/chronic fatigue syndrome and healthy controls: a systematic review and meta-analysis
title Comparison of serum acylcarnitine levels in patients with myalgic encephalomyelitis/chronic fatigue syndrome and healthy controls: a systematic review and meta-analysis
title_full Comparison of serum acylcarnitine levels in patients with myalgic encephalomyelitis/chronic fatigue syndrome and healthy controls: a systematic review and meta-analysis
title_fullStr Comparison of serum acylcarnitine levels in patients with myalgic encephalomyelitis/chronic fatigue syndrome and healthy controls: a systematic review and meta-analysis
title_full_unstemmed Comparison of serum acylcarnitine levels in patients with myalgic encephalomyelitis/chronic fatigue syndrome and healthy controls: a systematic review and meta-analysis
title_short Comparison of serum acylcarnitine levels in patients with myalgic encephalomyelitis/chronic fatigue syndrome and healthy controls: a systematic review and meta-analysis
title_sort comparison of serum acylcarnitine levels in patients with myalgic encephalomyelitis/chronic fatigue syndrome and healthy controls: a systematic review and meta-analysis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280864/
https://www.ncbi.nlm.nih.gov/pubmed/37337273
http://dx.doi.org/10.1186/s12967-023-04226-z
work_keys_str_mv AT jinushiryuhei comparisonofserumacylcarnitinelevelsinpatientswithmyalgicencephalomyelitischronicfatiguesyndromeandhealthycontrolsasystematicreviewandmetaanalysis
AT masudasakue comparisonofserumacylcarnitinelevelsinpatientswithmyalgicencephalomyelitischronicfatiguesyndromeandhealthycontrolsasystematicreviewandmetaanalysis
AT tanisakayuki comparisonofserumacylcarnitinelevelsinpatientswithmyalgicencephalomyelitischronicfatiguesyndromeandhealthycontrolsasystematicreviewandmetaanalysis
AT nishiguchisho comparisonofserumacylcarnitinelevelsinpatientswithmyalgicencephalomyelitischronicfatiguesyndromeandhealthycontrolsasystematicreviewandmetaanalysis
AT shionoyakento comparisonofserumacylcarnitinelevelsinpatientswithmyalgicencephalomyelitischronicfatiguesyndromeandhealthycontrolsasystematicreviewandmetaanalysis
AT satoryo comparisonofserumacylcarnitinelevelsinpatientswithmyalgicencephalomyelitischronicfatiguesyndromeandhealthycontrolsasystematicreviewandmetaanalysis
AT sugimotokei comparisonofserumacylcarnitinelevelsinpatientswithmyalgicencephalomyelitischronicfatiguesyndromeandhealthycontrolsasystematicreviewandmetaanalysis
AT shintakahiro comparisonofserumacylcarnitinelevelsinpatientswithmyalgicencephalomyelitischronicfatiguesyndromeandhealthycontrolsasystematicreviewandmetaanalysis
AT shiomirie comparisonofserumacylcarnitinelevelsinpatientswithmyalgicencephalomyelitischronicfatiguesyndromeandhealthycontrolsasystematicreviewandmetaanalysis
AT fujitaakashi comparisonofserumacylcarnitinelevelsinpatientswithmyalgicencephalomyelitischronicfatiguesyndromeandhealthycontrolsasystematicreviewandmetaanalysis
AT mizuidemasafumi comparisonofserumacylcarnitinelevelsinpatientswithmyalgicencephalomyelitischronicfatiguesyndromeandhealthycontrolsasystematicreviewandmetaanalysis
AT ryozawashomei comparisonofserumacylcarnitinelevelsinpatientswithmyalgicencephalomyelitischronicfatiguesyndromeandhealthycontrolsasystematicreviewandmetaanalysis